Laura Tiberio

Dr. Laura Tiberio

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2018 in Cellular & Molecular Immunology
Verified
Journal Article
Closed access
PDF file
LTLaura Tiberio
Laura Tiberio
APAnnalisa Del Prete
Annalisa Del Prete
TSTiziana Schioppa
Tiziana Schioppa
FSFrancesca Sozio
Francesca Sozio
Daniela BosisioDaniela Bosisio
Daniela Bosisio
SSSilvano Sozzani
Silvano Sozzani

22 September 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
VSValentina Salvi
Valentina Salvi
HNHoang Oanh Nguyen
Hoang Oanh Nguyen
FSFrancesca Sozio
Francesca Sozio
TSTiziana Schioppa
Tiziana Schioppa
CGCarolina Gaudenzi
Carolina Gaudenzi
Daniela BosisioDaniela Bosisio
Daniela Bosisio
The inflammatory and IFN pathways of innate immunity play a key role in the resistance and pathogenesis of coronavirus disease 2019 (COVID-19). Innate sensors and SARS-CoV-2–associated molecular patterns (SAMPs) remain to be completely defined. Here, we identified single-stranded RNA (ssRNA) fragments from the SARS-CoV-2 genome as direct activators of endosomal TLR7/8 and MyD88 pathway. The same sequences induced human DC activation in terms of phenotype and function, such as IFN and cytokine production and Th1 polarization. A bioinformatic scan of the viral genome identified several hundreds of fragments potentially activating TLR7/8, suggesting that products of virus endosomal processing potently activate the IFN and inflammatory responses downstream of these receptors. In vivo, SAMPs induced MyD88-dependent lung inflammation characterized by accumulation of proinflammatory and cytotoxic mediators and immune cell infiltration, as well as splenic DC phenotypical maturation. These results identified TLR7/8 as a crucial cellular sensor of ssRNAs encoded by SARS-CoV-2 involved in host resistance and the disease pathogenesis of COVID-19.

1 August 2017 in Current Opinion in Pharmacology
Verified
Journal Article
Closed access
APAnnalisa Del Prete
Annalisa Del Prete
TSTiziana Schioppa
Tiziana Schioppa
LTLaura Tiberio
Laura Tiberio
HSHelena Stabile
Helena Stabile
SSSilvano Sozzani
Silvano Sozzani

7 September 2017 in Blood
Verified
Journal Article
Open access
PDF file
APANNALISA DEL PRETE
ANNALISA DEL PRETE
LMLaura Martínez Muñoz
Laura Martínez Muñoz
CMCristina Mazzon
Cristina Mazzon
LTLara Toffali
Lara Toffali
FSFrancesca Sozio
Francesca Sozio
SSSilvano Sozzani
Silvano Sozzani
Key Points: CCRL2 is required for CXCR2-dependent neutrophil recruitment. CCRL2 forms heterodimers with CXCR2 and regulates CXCR2 signaling.

1 August 1997 in Liver International
Verified
Journal Article
Closed access
PDF file
LSLuisa Schiaffonati
Luisa Schiaffonati
LTLaura Tiberio
Laura Tiberio

Verified
Journal Article
Open access
PDF file
APANNALISA DEL PRETE
ANNALISA DEL PRETE
FSFrancesca Sozio
Francesca Sozio
IBIlaria Barbazza
Ilaria Barbazza
VSValentina Salvi
Valentina Salvi
LTLaura Tiberio
Laura Tiberio
SSSilvano Sozzani
Silvano Sozzani
Dendritic cells (DCs) constitute a complex network of cell subsets with common functions but also with many divergent aspects. All dendritic cell subsets share the ability to prime T cell response and to undergo a complex trafficking program related to their stage of maturation and function. For these reasons, dendritic cells are implicated in a large variety of both protective and detrimental immune responses, including a crucial role in promoting anti-tumor responses. Although cDC1s are the most potent subset in tumor antigen cross-presentation, they are not sufficient to induce full-strength anti-tumor cytotoxic T cell response and need close interaction and cooperativity with the other dendritic cell subsets, namely cDC2s and pDCs. This review will take into consideration different aspects of DC biology, including the functional role of dendritic cell subsets in both fostering and suppressing tumor growth, the mechanisms underlying their recruitment into the tumor microenvironment, as well as the prognostic value and the potentiality of dendritic cell therapeutic targeting. Understanding the specificity of dendritic cell subsets will allow to gain insights on role of these cells in pathological conditions and to design new selective promising therapeutic approaches.